Mónica Roxo-Rosa

Dr. Mónica Roxo-Rosa


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in Chemistry & Biology
Verified
Journal Article
Closed access
Carlos FarinhaCarlos Farinha
Carlos Farinha
JKJohn King-Underwood
John King-Underwood
MSMarisa Sousa
Marisa Sousa
ACAna Raquel Correia
Ana Raquel Correia
Bárbara HenriquesBárbara Henriques
Bárbara Henriques
MAMargarida Amaral
Margarida Amaral

21 November 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MRMónica Roxo-Rosa
Mónica Roxo-Rosa
ZXZhe Xu
Zhe Xu
ASAndré Schmidt
André Schmidt
MNMário Neto
Mário Neto
ZCZhiwei Cai
Zhiwei Cai
MAMargarida Amaral
Margarida Amaral
The revertant mutations G550E and 4RK [the simultaneous mutation of four arginine-framed tripeptides (AFTs): R29K, R516K, R555K, and R766K] rescue the cell surface expression and function of F508del-cystic fibrosis (CF) transmembrane conductance regulator (-CFTR), the most common CF mutation. Here, we investigate their mechanism of action by using biochemical and functional assays to examine their effects on F508del and three CF mutations (R560T, A561E, and V562I) located within a conserved region of the first nucleotide-binding domain (NBD1) of CFTR. Like F508del, R560T and A561E disrupt CFTR trafficking. G550E rescued the trafficking defect of A561E but not that of R560T. Of note, the processing and function of V562I were equivalent to that of wild-type (wt)-CFTR, suggesting that V562I is not a disease-causing mutation. Biochemical studies revealed that 4RK generates higher steady-state levels of mature CFTR (band C) for wt- and V562I-CFTR than does G550E. Moreover, functional studies showed that the revertants rescue the gating defect of F508del-CFTR with different efficacies. 4RK modestly increased F508del-CFTR activity by prolonging channel openings, whereas G550E restored F508del-CFTR activity to wt levels by altering the duration of channel openings and closings. Thus, our data suggest that the revertants G550E and 4RK might rescue F508del-CFTR by distinct mechanisms. G550E likely alters the conformation of NBD1, whereas 4RK allows F508del-CFTR to escape endoplasmic reticulum retention/retrieval mediated by AFTs. We propose that AFTs might constitute a checkpoint for endoplasmic reticulum quality control.

28 February 2013 in Molecules
Verified
Journal Article
Open access
PDF file
XRXavier Ragàs
Xavier Ragàs
XHXin He
Xin He
Montserrat AgutMontserrat Agut
Montserrat Agut
MRMónica Roxo-Rosa
Mónica Roxo-Rosa
AGAntónio Rocha Gonsalves
António Rocha Gonsalves
SNSanti Nonell
Santi Nonell
Several families of photosensitizers are currently being scrutinized for antimicrobial photodynamic therapy applications. Differences in physical and photochemical properties can lead to different localization patterns as well as differences in singlet oxygen production and decay when the photosensitizers are taken up by bacterial cells. We have examined the production and fate of singlet oxygen in Escherichia coli upon photosensitization with three structurally-different cationic photosensitizers, namely New Methylene Blue N (NMB), a member of the phenothiazine family, ACS268, a hydrophobic porphyrin with a single cationic alkyl chain, and zinc(II)-tetramethyltetrapyridinoporphyrazinium salt, a phthalocyanine-like photosensitizer with four positive charges on the macrocycle core. The kinetics of singlet oxygen production and decay indicate different localization for the three photosensitizers, whereby NMB appears to localize in an aqueous-like microenvironment, whereas ACS268 localizes in an oxygen-shielded site, highly reactive towards singlet oxygen. The tetracationic zinc(II) tetrapyridinoporphyrazine is extensively aggregated in the bacteria and fails to produce any detectable singlet oxygen.

2 October 2015 in Biology Open
Verified
Journal Article
Open access
PDF file
MRMónica Roxo-Rosa
Mónica Roxo-Rosa
AJAna Raquel Marques Jacinto
Ana Raquel Marques Jacinto
PSPedro Sampaio
Pedro Sampaio
SLSusana Santos Lopes
Susana Santos Lopes
In autosomal dominant polycystic kidney disease (ADPKD), cyst inflation and continuous enlargement are associated with marked transepithelial ion and fluid secretion into the cyst lumen via cystic fibrosis transmembrane conductance regulator (CFTR). Indeed, the inhibition or degradation of CFTR prevents the fluid accumulation within cysts. The in vivo mechanisms by which the lack of Polycystin-2 leads to CFTR stimulation are an outstanding challenge in ADPKD research and may bring important biomarkers for the disease. However, hampering their study, the available ADPKD in vitro cellular models lack the three-dimensional architecture of renal cysts and the ADPKD mouse models offer limited access for live-imaging experiments in embryonic kidneys. Here, we tested the zebrafish Kupffer9s vesicle (KV) as an alternative model-organ. KV is a fluid-filled vesicular organ, lined by epithelial cells that express both CFTR and Polycystin-2 endogenously, being each of them easily knocked-down. Our data on the intracellular distribution of Polycystin-2 support its involvement in the KV fluid-flow induced Ca2+-signalling. Mirroring kidney cysts, the KV lumen inflation is dependent on CFTR activity and, as we clearly show, the knockdown of Polycystin-2 results in larger KV lumens through overstimulation of CFTR. In conclusion, we propose the zebrafish KV as a model organ to study the renal cyst inflation. Favouring its use, KV volume can be easily determined by in vivo imaging offering a live readout for screening compounds and genes that may prevent cyst enlargement through CFTR inhibition.

22 March 2006 in Proteomics
Verified
Journal Article
Closed access
PDF file
MRMónica Roxo-Rosa
Mónica Roxo-Rosa
GCGonçalo da Costa
Gonçalo da Costa
TLTheo M. Luider
Theo M. Luider
BSBob J. Scholte
Bob J. Scholte
Ana Varela CoelhoAna Varela Coelho
Ana Varela Coelho
Deborah PenqueDeborah Penque
Deborah Penque

1 August 2004 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
PDF file
Carlos FarinhaCarlos Farinha
Carlos Farinha
Deborah PenqueDeborah Penque
Deborah Penque
MRMónica Roxo-Rosa
Mónica Roxo-Rosa
Gergely LukacsGergely Lukacs
Gergely Lukacs
RDRobert Dormer
Robert Dormer
MAMargarida Amaral
Margarida Amaral